Literature DB >> 66218

Present status of MA-160 cell line. Prostatic epithelium or HeLa cells.

M M Webber, P K Horan, T R Bouldin.   

Abstract

This report reviews the background and the present status of the MA-160 cell line. This cell line was reported to have arisen from tissue cultures of a human, benign prostatic adenoma and consequently has been used for investigations on the prostat and on hormone-dependent cells. Recent studies using chromosome analysis by banding techniques, glucose-6-phosphate dehydrogenase (G6D) electrophoretic mobility, and a specific prostatic acid phosphatase test indicate that MA-160 is not of prostatic origin but a HeLa cell contaminant, arising as a result of intraspecies cell contamination. It is suggested that whenever spontaneous transformation is observed in vitro and established cell lines are being used in the laboratory, the cells in question be thoroughly checked with the currently available chromosomal, biochemical, and cytochemical methods in order to establish their origin and to rule out interspecies and intraspecies cell contamination.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 66218

Source DB:  PubMed          Journal:  Invest Urol        ISSN: 0021-0005


  4 in total

1.  LCC15-MB cells are MDA-MB-435: a review of misidentified breast and prostate cell lines.

Authors:  Erik W Thompson; Mark Waltham; Susan J Ramus; Anne-Marie Hutchins; Jane E Armes; Ian G Campbell; Elizabeth D Williams; Phillip R Thompson; James M Rae; Michael D Johnson; Robert Clarke
Journal:  Clin Exp Metastasis       Date:  2004       Impact factor: 5.150

2.  MA 160 and EB33 cell lines: HeLa cell contaminants, hybrids or prostatic epithelial cells?

Authors:  J E Pontes; J M Pierce; B K Choe; N R Rose
Journal:  In Vitro       Date:  1979-07

3.  Isolation, in vitro cultivation, and electron microscopy of normal and malignant prostatic epithelial cells from the Copenhagen rat.

Authors:  F A Feuchter; D R Rowley; P M Heidger
Journal:  Urol Res       Date:  1980

4.  Chemical alternative for cell identification and cross-contamination detection.

Authors:  Dhouha Msalbi; Jihene Elloumi-Mseddi; Bochra Hakim; Emna Sahli; Sami Aifa
Journal:  3 Biotech       Date:  2022-02-25       Impact factor: 2.406

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.